Editorial on the Research Topic

HSPs-Ambiguous Mediators of Immunity
Heat shock proteins (HSPs) were discovered as polypeptides induced by stress that can be found in all kingdoms of cellular organisms. Their functions were, a first enigmatic and these proteins were thus classified by molecular weight, as in-Hsp27, Hsp70, Hsp90, Hsp110 (1) . More recently, each of these size-classified molecules has attributed a role in protein folding, and they thus came to be known, as a class, as molecular chaperones-deterrents of unsuitable interactions between intracellular proteins (2). However, the HSPs possess properties beyond chaperoning. Indeed, their discovery in the extracellular spaces suggested roles in intercellular signaling and in the convoluted regulation of the immune responses.
A number of lines of investigation triggered interest in HSPs as mediators of immunity. Srivastava and others found that the molecular chaperone properties of HSPs could be harnessed in cancer vaccine design (3) (4) (5) . They emphasized the role of HSPs in capturing tumor antigens and permitting their uptake and processing by antigen-presenting cells (APCs) prior to activation of cytotoxic lymphocytes. Others suggested that HSPs could behave like endogenous danger signals when flooding into the extracellular microenvironment after cell death (6) . In another line of investigation, investigators studied the role of mycobacterial Hsp65 and Hsp70 in suppression of autoimmune diseases such as arthritis, diabetes, and prolongation of tissue grafts [Borges et al.; (7, 8) ]. HSPs were thus implicated in contrasting and apparently opposed aspects of immunity.
The current volume contains articles dealing with these aspects of HSP biology. Thus, from the analysis contained in this collection of articles, we appear to have come a long way in past 30 years in understanding "the other face of HSP biology"-the various families of HSPs escaping to the extracellular milieu and influencing immunity. However, much remains to be learned in terms of the recognition of HSPs by receptors on APC, in cell signaling and in understanding how these events are influenced by tissue context. In addition, the complex pathways undertaken by HSP-chaperoned peptides in the intracellular milieu and their influence on antigen presentation remain to be fully characterized. In terms of translation of HSP research to disease treatment, promising approaches to cancer immunotherapy, treatment of inflammatory disease such as arthritis and survival of tissue transplants appear to beckon. This area of HSP biology thus appears to have rich promise for the future.
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